Miramar Labs, Inc.® Appoints Patrick F. Williams To Board of Directors
August 30 2016 - 8:00AM
Miramar Labs, Inc., (OTCQB:MRLB), a global aesthetic company,
announced today the appointment of Patrick F. Williams to the
Company’s Board of Directors. Mr. Williams will serve as Chairman
of the Audit Committee, bringing nearly 20 years of financial
management experience.
“We are extremely pleased to have Patrick join
Miramar’s Board of Directors. His strong background in the medical
device industry, including his experience guiding a market leading,
global aesthetic device company will be an invaluable addition to
the Company. In addition, Patrick’s extensive knowledge of the
financial and strategic aspects of a rapidly growing device company
will be beneficial to the team,” commented Mike Kleine, Chief
Executive Officer of Miramar.
Mr. Williams said, “I am excited to join the Board
of Directors of Miramar. The Company has a significant opportunity
to penetrate the large and growing market of 220 million people
globally who suffer from excessive, uncontrollable sweating. I look
forward to working with the team as the Company continues to expand
awareness and adoption of miraDry®.”
Mr. Williams most recently served as Senior Vice
President and Chief Financial Officer at ZELTIQ Aesthetics,
(NASDAQ:ZLTQ), a medical technology company focused on developing
and commercializing products utilizing its proprietary
controlled-cooling technology platform. Mr. Williams was at ZELTIQ
for approximately four years and was responsible for executive
management of the finance and investor relations functions,
development of the worldwide budget and forecast, and
implementation of necessary infrastructure changes to support
top-line growth and operating margin expansion.
Prior to ZELTIQ, Mr. Williams served in several
financial leadership positions at NuVasive, a medical device
company focused on developing minimally disruptive surgical
products and procedurally integrated solutions for the spine,
including serving as Vice President of Strategy and Investor
Relations and Vice President of Finance and Investor Relations.
Mr. Williams received an MBA in Finance and
Management from San Diego State University and a Bachelor of Arts
in Economics from University of California, San Diego.
About Miramar LabsMiramar Labs,
Inc., is a global medical device company dedicated to bringing
innovative and clinically proven applications to treat unmet needs
in the aesthetic marketplace. Supported by rigorous clinical
research, Miramar Labs is focused on addressing medical conditions
for which there are significant unmet clinical needs. The company’s
first priority is the treatment of bothersome underarm sweat, an
issue that hundreds of millions of people deal with daily. The
miraDry® procedure has an established safety and efficacy profile
with over 70,000 patients treated worldwide. Physicians and
patients are encouraged to visit www.miramarlabs.com or
www.miradry.com for additional information.
Contacts:
Investors:
Brigid Makes
Sr. Vice President & CFO
408-579-8700
investors@miramarlabs.com
Nick Laudico or Zack Kubow
The Ruth Group
646-536-7030 / 7020
nlaudico@theruthgroup.com
zkubow@theruthgroup.com
Zeltiq Aesthetics, Inc. (NASDAQ:ZLTQ)
Historical Stock Chart
From Mar 2024 to Apr 2024
Zeltiq Aesthetics, Inc. (NASDAQ:ZLTQ)
Historical Stock Chart
From Apr 2023 to Apr 2024